News

July 13, 2022
Medical Research

Fulcrum Phase 3 FSHD Clinical Trial Using AMRA Medical’s Whole-body MRI Measurements as a Key Secondary Endpoint

REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA’s Muscle Fat Infiltration (MFI) as a secondary endpoint. AMRA…
Read More
July 5, 2022
Medical Research

AMRA Medical continues to advance FSHD research with whole-body MRI measurements

AMRA’s recent publication demonstrates the utility of MRI-based muscle composite scores in neuromuscular disease clinical trials. AMRA Medical, a digital health company delivering a…
Read More
June 23, 2022
Medical Research

AMRA Biomarkers Indicate Individuals with CVD and T2D Have Faster Muscle Deterioration than Metabolically Disease-Free People — AMRA Medical to Present Data at SCWD

AMRA Medical will present “Two years of aging – initial results on changes in muscle composition in the UK Biobank imaging study” at SCWD,…
Read More
June 13, 2022
Medical Device

Human Longevity, Inc. adds AMRA® BCP Scan by AMRA Medical to the world’s most advanced precision longevity care program

AMRA Medical today announced they have signed a definitive agreement with Human Longevity Inc. (HLI) to offer AMRA® BCP Scan Report to its members…
Read More
June 1, 2022
Medical Device

AMRA Webinar. From BMI to BCP: Body Composition Profiling with MRI for Metabolic Disease Management, Health Risks & Healthy Lifestyle Choices

In the search to understand metabolic disease, prevention and treatments, people are often broadly categorized using relatively crude tools. This removes the individualized perspective….
Read More
May 31, 2022
Medical Device

AMRA®MAsS Scan – Introducing an Objective Way to Help Clinicians Assess Muscle Health at ATC 2022

AMRA will be in Boston for the American Transplant Congress (ATC 2022) on June 4 – 8. We will be happy to meet with…
Read More
April 26, 2022
Medical Research

AMRA Medical’s MRI-based body composition measurements used in Lilly’s SURPASS-3 tirzepatide sub-study

Eli Lilly and Company assessed the impact of tirzepatide, an investigational therapy for the treatment of type 2 diabetes, on liver fat, visceral fat,…
Read More
March 24, 2022
Medical Research

AMRA Webinar: The Patient Experience Using MRI in DMD Clinical Trials – “Shed Light Through MRI”

Join us – with patients, industry leaders and a patient advocacy group to learn how to implement a magnetic resonance imaging (MRI) study designed…
Read More
March 14, 2022
Medical Research

AMRA Medical, Daiichi Sankyo and NCNP joint MRI-based muscle research accepted for poster presentation at 2022 MDA Conference

LINKÖPING, Sweden; March 14, 2022—AMRA’s recent research, performed in collaboration with Daiichi Sankyo and the National Center of Neurology and Psychiatry (NCNP) in Japan,…
Read More
February 23, 2022
Medical Device

AMRA Medical’s MRI-Based Fat & Muscle Assessment Technology Approved for Clinical Use in US and Canada

LINKÖPING, Sweden; February 23, 2022—AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and medical research…
Read More

© 2022 AMRA Medical AB

By using our site, you acknowledge that you have read and understood our privacy policy. We use cookies to ensure you have the best browsing experience on our website.
Accept & Close